Paul Edick | Chairman, Chief Executive Officer |
Barry Deutsch | Chief Financial Officer |
Allison Wey | Senior Vice President of Investor Relations & Corporate Communication |
Zach Sachar | Piper Sandler |
Ed Chung | Jefferies |
Daniel Busby | RBC Capital Markets |
Ladies and gentlemen, thank you for standing by and welcome to the Xeris Pharmaceuticals Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is bring recorded.